eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation.
eGenesis is uniquely positioned to reinvigorate the field of xenotransplantation by addressing both the key virology and immunology hurdles that have impeded its advancement to date and provide commercially-viable products to save and enhance the lives of patients in need.
eGenesis is uniquely positioned to reinvigorate the field of xenotransplantation by addressing both the key virology and immunology hurdles that have impeded its advancement to date and provide commercially-viable products to save and enhance the lives of patients in need.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $454M
Founded date: 2015
Investors 7
| Date | Name | Website |
| - | Altium Cap... | altiumcap.... |
| - | Alta Partn... | altapartne... |
| - | Khosla Ven... | khoslavent... |
| - | T1D Fund | t1dfund.or... |
| - | Wellington... | wellington... |
| - | HBM Partne... | hbmpartner... |
| - | SymBiosis | symbiosis.... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 04.09.2024 | Series B | $191M | - |
| 02.03.2021 | Series C | $125M | - |
| 07.11.2019 | Series B | $100M | - |
| 16.03.2017 | Series A | $38M | - |
Mentions in press and media 23
| Date | Title | Description |
| 24.02.2025 | OrganOx Closes $142M Equity Financing | OrganOx, an Oxford, UK-based organ medical technology company, raised $142M in equity funding. The round was led by new investor HealthQuest Capital with participation from existing investors BGF and Lauxera Capital Partners, along with add... |
| 30.01.2025 | The Future of Transplants: Pig Organs and Genetic Diversity | In a world where the demand for organ transplants outstrips supply, a glimmer of hope emerges from an unexpected source: pigs. The story of a woman named Looney, who received a genetically modified pig kidney, marks a significant milestone ... |
| 27.01.2025 | Health | The only person in the world with a functioning pig organ is thriving after a record 2 months | “We’re quite optimistic that this is going to continue to work and work well for, you know, a significant period of time,” he said. Scientists are genetically altering pigs so their organs are more humanlike to address a severe shortage of ... |
| 04.09.2024 | eGenesis Raises $191M in Series B Funding | eGenesis, a Cambridge, MA-based biotechnology company developing human-compatible engineered organs to address the global organ shortage, raised $191M in Series B funding. The round was led by Lux Capital, with participation from existing i... |
| 04.09.2024 | Natco Pharma’s Canadian arm invests $8 million in eGenesis | Natco Pharma’s wholly-owned Canadian subsidiary, Natco Pharma (Canada) Inc., invested $8 million in the US-based biotechnology company, eGenesis, Inc. “We are excited to get involved with eGenesis, Inc. with respect to their pioneering work... |
| 04.09.2024 | eGenesis: $191 Million (Series D) Secured To Develop Engineered Organs For Addressing Transplant Shortages | eGenesis, a biotechnology company that is developing human-compatible engineered organs to address the global organ shortage, announced today the closing of a $191 million Series D financing. The funding was led by Lux Capital, with partici... |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадили человеку. Теперь их можно массово пересаживать... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной свиньи. СМИ сообщают, что данная операция является прорывом в области ксенотрансплантации, когда органы, клетки или ткани пересаживаются из одн... |
| 11.10.2023 | In major test for eGenesis, gene-edited pig kidneys kept monkeys alive for more than two years | Scientists at a Massachusetts-based biotechnology company and their academic research partners reported Wednesday that an engineered breed of miniature pig containing up to 69 genetic changes produced kidneys that functioned well in monkeys... |
| 29.04.2021 | High Turnover? Here's How To Find (And Address) The Root Cause | An employee comes to human resources to put in their resignation. Just as you've found someone to fill their now-open position, another employee gives their notice as well. Soon, it becomes clear that your company is facing a turnover probl... |
| 02.03.2021 | eGenesis Announces $125 Million Series C Financing | Proceeds will advance two lead xenotransplantation programs in kidney failure and type 1 diabetes into first-in-human studies. |
Show more